Open Source Health · Mental Health
Depression, anxiety, and most mental health conditions have measurable physiological drivers: neuroinflammation, gut dysbiosis, mitochondrial dysfunction, nutritional deficiency, trauma-encoded nervous system patterns. This is what the system almost never looks for, and what happens when you do.
The label describes the experience.
The question is what is generating it.
That question is almost never asked.
What Mental Health Actually Is
Mental health conditions are real. The suffering is real. The disruption they cause is real. What is incomplete is the model that explains them as primarily chemical imbalances corrected by drugs. The chemical imbalance theory of depression, specifically serotonin deficiency, has been substantially revised in the research literature. A 2022 umbrella review in Molecular Psychiatry found no consistent evidence supporting the serotonin deficiency hypothesis for depression. This did not make headlines proportionate to how confidently the hypothesis had been stated for decades to justify SSRI prescriptions.
The emerging picture is more complex and more actionable. Neuroinflammation, inflammation inside the brain mediated by activated microglial cells, is now recognized as a primary driver of depression, anxiety, cognitive decline, and several other conditions. The brain's immune cells, when chronically activated by peripheral inflammation crossing the blood-brain barrier, by gut-derived LPS, by traumatic stress, or by metabolic dysfunction, produce inflammatory cytokines that directly alter neurotransmitter function, neuroplasticity, and the hypothalamic-pituitary axis regulation of stress hormones.
The gut-brain axis is the most important concept in modern psychoneuroimmunology. Ninety percent of serotonin is produced in the gut. The vagus nerve carries continuous signals from the gut to the brain. Gut microbiome composition directly influences neurotransmitter production, inflammatory status, and the stress response system. A person with significant gut dysbiosis has a disrupted serotonin production system, a disrupted GABAergic signaling system, and a chronically upregulated immune-inflammatory axis. All three directly affect mood, anxiety, and cognition.
Trauma does not only live in memory. It is encoded in the nervous system, in the autonomic regulation patterns, the HPA axis response, the interoceptive processing, and the inflammatory biology. Adverse childhood experiences produce measurable long-term alterations in HPA axis function, inflammatory cytokine levels, gut microbiome composition, and brain structure. These are not psychological weaknesses. They are biological adaptations to unsafe conditions. They are also modifiable, through the right approaches, in adults who experienced them.
Microglia are the brain's resident immune cells. Chronically activated by peripheral inflammation, infections, trauma, gut-derived LPS, or metabolic dysfunction, they produce cytokines that impair neuroplasticity, alter neurotransmitter synthesis and reuptake, and disrupt the HPA axis. Neuroinflammation is measurable and is present in a significant proportion of people with treatment-resistant depression.
90 percent of serotonin is produced in the gut by enterochromaffin cells. Gut dysbiosis disrupts this production. The vagus nerve carries continuous gut status signals to the brain. Gut bacteria produce GABA, short-chain fatty acids that cross the blood-brain barrier, and inflammatory signals that directly alter brain function. Restoring the gut often restores mental health in ways that SSRIs cannot.
The brain consumes 20 percent of the body's total energy output despite representing 2 percent of its mass. Mitochondrial dysfunction, impairing cellular energy production, hits the brain disproportionately. It is documented in depression, bipolar disorder, and schizophrenia. Viral infections, chronic stress, nutritional deficiency, and toxin exposure all impair mitochondrial function. This is a treatable biological factor in treatment-resistant mental health conditions.
Unresolved trauma maintains the nervous system in a chronic threat state: elevated cortisol, sympathetic dominance, heightened amygdala reactivity, impaired prefrontal regulation. This is not a memory problem. It is an autonomic regulation problem. The nervous system cannot come down from alert. All of its downstream effects, on sleep, inflammation, gut, immune function, and cognition, are active and ongoing.
The SSRI addresses a neurotransmitter.
It does not address neuroinflammation,
gut dysbiosis, or what the trauma encoded.
What the System Gets Wrong
The mental health system is under profound strain, operating with a model that reduces complex biological and experiential conditions to diagnostic categories and neurotransmitter interventions. The model produces some relief for some people. For the substantial percentage with treatment-resistant conditions, it offers escalation of the same approach rather than a different one.
SSRIs inhibit serotonin reuptake, increasing the concentration of serotonin in the synaptic cleft. For some people this is meaningfully helpful. For many it is partially helpful and tolerance develops. For a significant subset it is not helpful or produces side effects that are themselves debilitating (sexual dysfunction, emotional blunting, weight gain, withdrawal effects). The missing conversation: why is serotonin signaling impaired? Is it gut dysbiosis reducing serotonin production? Neuroinflammation impairing receptor function? Nutritional deficiency in tryptophan or its cofactors B6 and zinc? These questions are almost never asked before the prescription is written.
A standard psychiatric evaluation assesses symptoms and history. It does not include hs-CRP to assess neuroinflammatory burden, vitamin D levels (deficiency is strongly associated with depression), B12 and folate (both required for neurotransmitter synthesis), complete thyroid panel (hypothyroidism produces depression identical to primary depression), comprehensive stool analysis, or omega-3 index. Any of these could be a primary driver of the presenting symptoms. None are standard. The psychiatric evaluation treats the brain as if it exists independently of the body it sits in.
Trauma produces measurable biological changes: HPA axis dysregulation, altered amygdala reactivity, reduced hippocampal volume, chronic low-grade inflammation, gut microbiome disruption. These are not metaphors. They are structural and functional changes in the nervous system that medications do not address. Talk therapy, when not trauma-informed and somatic, processes narrative without discharging the autonomic threat state. Somatic approaches (Somatic Experiencing, EMDR, Internal Family Systems) address the nervous system directly. These are significantly underutilized relative to their evidence base.
Exercise reduces depression symptoms with effect sizes comparable to antidepressants in multiple meta-analyses. It reduces neuroinflammation, increases BDNF (brain-derived neurotrophic factor, required for neuroplasticity), regulates the stress axis, and improves sleep, all through mechanisms directly relevant to depression. Mediterranean dietary pattern reduces depression risk significantly across population studies. These are not weak or alternative interventions. They are the strongest evidence-based treatments available. They are presented as suggestions alongside pharmacological treatment rather than as primary interventions.
When a person does not respond to one SSRI, the standard response is a different SSRI, then an augmentation agent, then a different class of antidepressant. The question rarely asked is why the physiology is not responding to serotonergic approaches. Neuroinflammation impairs response to SSRIs independently of serotonin levels. Omega-3 deficiency reduces antidepressant response. Untreated thyroid dysfunction prevents antidepressant efficacy. Unresolved trauma maintains the HPA axis dysregulation that pharmacology cannot fully override. These factors are not exotic. They are common. They are findable. They change the clinical approach when they are found.
Root Cause Map
Mental health conditions driven by different biological mechanisms have overlapping symptom presentations. The contextual features, what worsens it, what improves it, and what coexists with it, often point toward the primary driver.
The nervous system learned these patterns
for a reason. They kept you safe.
The work is not to fight them. It is to show them they are no longer needed.
Natural Restoration Toolkit
These interventions address the physiological drivers of mental health conditions. They do not replace appropriate psychiatric care for severe conditions. For many people with mild to moderate depression, anxiety, or mood disruption, they produce significant relief by addressing root causes that medication does not reach.
EPA reduces neuroinflammation and enhances antidepressant response. DHA is a structural component of neuronal membranes required for normal synaptic function. Studies on omega-3 supplementation in depression show effect sizes comparable to low-dose antidepressants, with benefits increasing when omega-3 is combined with pharmacological treatment. EPA-dominant formulations (at least 60 percent EPA) at 2 to 4g daily show the strongest antidepressant signal. Effects build over 6 to 8 weeks. One of the safest interventions with broad biological benefit beyond mental health.
Magnesium modulates NMDA receptors, which when overactivated produce anxiety and excitotoxicity. It supports GABA function, the primary inhibitory neurotransmitter. It reduces cortisol production and improves sleep architecture. Deficiency is documented in depression and anxiety. Low magnesium increases stress reactivity, creating a cycle that supplementation can break. Glycinate form crosses the blood-brain barrier more effectively and is better tolerated than oxide or citrate. 300 to 400mg before bed. This is the supplement with the strongest physiological case for mental health support.
Vitamin D receptors are found throughout the brain, including in regions involved in mood regulation. Vitamin D directly upregulates serotonin synthesis genes and supports the production of BDNF, the growth factor required for neuroplasticity. Deficiency is independently associated with depression and seasonal affective disorder. Optimal levels for mental health appear to be in the 60 to 80 ng/mL range. Test first. Supplement at 5,000 to 10,000 IU daily with K2. Retest at 90 days to confirm target reached.
B6, B12, and folate are essential cofactors in neurotransmitter synthesis. B6 converts tryptophan to serotonin and supports GABA production. Folate is required for the methylation cycle that produces neurotransmitters. B12 deficiency produces depression and cognitive decline that is neurologically indistinguishable from primary psychiatric conditions. Use methylated forms (methylfolate, methylcobalamin) as approximately 40 percent of people have MTHFR variants impairing folic acid conversion. A comprehensive B complex with methylated B12 and folate is a reasonable foundation for anyone with mood or cognitive concerns.
Gut restoration is often the missing piece in treatment-resistant mood conditions. A dysbiotic gut produces less serotonin, more inflammatory signaling, and more LPS-driven neuroinflammation. L-glutamine for gut lining integrity, multi-strain probiotics, elimination of inflammatory dietary triggers, and fermented foods for microbial diversity. The effects on mood when a significantly dysbiotic gut is restored are often dramatic and rapid relative to pharmacological interventions. See the Gut Health guide for the full protocol.
Aerobic exercise increases BDNF production, reduces inflammatory cytokines, normalizes the HPA axis stress response, improves sleep, produces endorphins and endocannabinoids, and grows new hippocampal neurons (hippocampal neurogenesis is one of the proposed mechanisms of antidepressant action). Meta-analyses consistently show exercise reducing depression with effect sizes matching antidepressants. The dose that produces antidepressant effects: 30 to 45 minutes of moderate intensity aerobic exercise 3 to 5 times weekly. Starting is the hardest part. The benefit is real from the first session and cumulative over weeks.
Morning sunlight exposure within 30 minutes of waking triggers the cortisol awakening response that sets the circadian clock. Correct circadian timing regulates serotonin production, melatonin timing, and the dopamine reward pathway. It is also the primary trigger for vitamin D synthesis. Seasonal affective disorder is the extreme end of what disrupted circadian light signaling does to mood. Non-seasonal depression also benefits from morning light. 10 to 20 minutes of outdoor morning light daily is a free, side-effect-free intervention that belongs in every mental health protocol.
Traditional talk therapy processes the narrative and meaning of traumatic events. Somatic approaches address the physiological threat response that is encoded in the body independent of the narrative. Somatic Experiencing, EMDR, Internal Family Systems, and Sensorimotor Psychotherapy all work at the level of the autonomic nervous system, the body sensation, and the movement impulse that was interrupted during trauma. The evidence base for EMDR in PTSD is particularly strong. These approaches do not require revisiting the narrative in detail. They work by completing the physiological response the nervous system was prevented from completing.
The vagus nerve is the primary pathway of the parasympathetic nervous system. Slow, controlled breathing with extended exhale directly activates vagal tone, reducing heart rate, lowering cortisol, reducing inflammatory cytokines through the cholinergic anti-inflammatory pathway, and shifting autonomic balance toward parasympathetic recovery. 4-7-8 breathing (4 count inhale, 7 count hold, 8 count exhale), box breathing, and coherence breathing at 5.5 breaths per minute all produce measurable HRV improvements. This is one of the most accessible, evidence-supported interventions in mental health and one of the most underused.
L-theanine increases alpha brain wave activity, the pattern associated with calm, relaxed alertness. It also modulates GABA and glutamate activity, reducing excitatory signaling without the sedation or dependence of pharmaceutical anxiolytics. Studies show dose-dependent reduction in subjective anxiety and stress response. 100 to 400mg for acute anxiety situations. Pairs well with magnesium for broader nervous system support. No known dependence, tolerance, or drug interactions at standard doses. The closest thing to an anxiety supplement with genuine evidence.
Real Questions
I have been on antidepressants for five years and I am not sure they are working anymore. What do I do?
This is one of the most common and most difficult situations in mental health care and it deserves a direct, honest answer. Antidepressant tolerance is real. The dose that worked initially may produce less effect over time as receptors adapt. The baseline mood that was improved may have drifted back. Or the medication is providing a floor but the underlying biological drivers have not been addressed and the ceiling is low.
Before changing or stopping medication, assess what has been done about the root causes. Has gut health been evaluated and addressed? Have vitamin D, B12, and omega-3 status been optimized? Has exercise been consistent? Is sleep architecture good? Has trauma been addressed through a somatic approach? If the answer to most of these is no, there is substantial physiological ground to cover before concluding that the medication is the problem.
If you want to stop or reduce the medication, do not do it abruptly. Antidepressant discontinuation syndrome is real and can be severe. A hyperbolic taper, reducing by very small amounts over months, produces the safest discontinuation. This should be done with a prescriber who understands the taper process. The prescriber who put you on the medication is not always the right person to manage the taper. Psychiatrists who specialize in discontinuation exist and are worth finding if this is your situation.
My anxiety is constant. I have tried therapy and medication and neither has fully worked. What am I missing?
The most commonly missed factors in treatment-resistant anxiety are physiological, not psychological. The three to evaluate first: magnesium deficiency (directly impairs GABA function and increases stress reactivity), gut dysbiosis (disrupts GABA and serotonin production, increases inflammatory signaling that maintains anxiety), and trauma-encoded nervous system dysregulation (which talk therapy addresses at the narrative level but does not discharge at the physiological level).
Specific tests worth requesting: magnesium RBC level (more sensitive than serum), comprehensive stool analysis if gut symptoms coexist, vitamin D serum level, full thyroid panel (hyperthyroidism and Hashimoto's both produce anxiety symptoms), and cortisol rhythm testing (salivary cortisol at four time points across the day to assess whether the HPA axis is dysregulated in a way that maintains a chronic anxiety state).
On the nervous system side: if there is a significant trauma history and the anxiety is characterized by hypervigilance, startling easily, difficulty being in public spaces, or a sense of impending danger without identifiable cause, somatic therapy specifically should be on the table. Talk therapy and CBT process the thought content of anxiety. Somatic therapy addresses the nervous system state that is generating the thought content. Both are useful. For trauma-driven anxiety, the somatic approach often produces what cognitive approaches cannot.
I was told I have bipolar disorder. The medications have serious side effects. Is there anything else?
Bipolar disorder is one of the mental health conditions with the strongest evidence for physiological drivers that are addressable alongside medication. The physiological factors most associated with bipolar disorder: mitochondrial dysfunction (lithium's mechanism of action includes mitochondrial protection, which is not a coincidence), omega-3 deficiency (EPA and DHA reduce manic and depressive episode frequency in several clinical trials), circadian rhythm disruption (disrupted sleep is one of the most reliable triggers for mood episodes), and neuroinflammation.
This does not mean medication is optional for bipolar disorder. Severe manic or depressive episodes represent genuine safety risks and mood stabilizers are often appropriate. The question is whether the physiological contributors are being addressed alongside medication, which they almost never are. Omega-3 supplementation at 3 to 4g EPA/DHA daily has sufficient evidence in bipolar disorder to be considered a genuine adjunctive treatment. Mitochondrial support (CoQ10, NAC, magnesium) addresses the energy metabolism dimension. Circadian rhythm protection, consistent sleep and wake times and light exposure, reduces episode frequency.
The side effect question is legitimate. Lithium requires regular blood monitoring and has a narrow therapeutic window. Valproate has significant teratogenicity concerns and metabolic effects. Atypical antipsychotics have metabolic and movement-related side effects. Discussing the minimum effective dose, exploring whether any agents can be reduced as physiological drivers are addressed, and working with a psychiatrist who is knowledgeable about integrative approaches is reasonable and worth pursuing.
I have had depression my whole adult life. Could it actually be something physical that was never found?
Yes. Lifelong depression without identifiable psychological precipitant and without adequate response to treatment is one of the strongest indicators that a physiological driver was never found.
The most commonly missed physiological causes of chronic depression: subclinical hypothyroidism (treated with TSH-only testing that misses functional conversion problems), vitamin B12 deficiency (produces neurological depression that is clinically indistinguishable from primary depression and resolves with B12 repletion), MTHFR gene variant producing folate metabolism impairment and reduced neurotransmitter synthesis (treatable with methylated B vitamins), omega-3 deficiency, gut dysbiosis causing reduced serotonin production, vitamin D deficiency, and undiagnosed sleep apnea (produces depression, cognitive impairment, and fatigue that resolves completely with treatment).
A comprehensive physiological evaluation including full thyroid panel, methylated B12 and folate, MTHFR genotyping, omega-3 index, vitamin D, hs-CRP, comprehensive metabolic panel, and fasting insulin, combined with a sleep study if sleep quality has never been formally assessed, addresses the most common missed biological drivers. This is not an exotic workup. It is basic biology applied to a problem that has been treated as purely psychiatric for a lifetime.
I experienced significant trauma as a child and I have had anxiety, depression, and physical health problems my whole life. Are these connected?
Yes. The evidence for this connection is extensive, longitudinal, and not contested in the research literature even though it is rarely discussed in clinical settings.
The ACE (Adverse Childhood Experiences) studies, which began in the 1990s and have been replicated in multiple countries, documented dose-response relationships between the number of adverse childhood experiences and the prevalence of depression, anxiety, autoimmune disease, chronic pain, cardiovascular disease, cancer, diabetes, and early mortality. This is not a small effect. People with four or more ACEs have dramatically higher rates of every chronic health condition studied.
The mechanisms are understood. Early trauma produces persistent HPA axis dysregulation, altered immune function with elevated inflammatory markers, gut microbiome disruption, epigenetic changes in stress-response genes, reduced hippocampal volume, and altered amygdala reactivity. These are not metaphors. They are biological. They produce both the mental health conditions and the physical health conditions that co-occur in people with significant trauma histories.
The most important thing to know about this: it is not fixed. Neuroplasticity, epigenetic flexibility, and the body's capacity for physiological restoration are real at every age. The biology can shift. Somatic therapy addresses the nervous system encoding. Physical interventions address the inflammatory, gut, and hormonal dimensions. The connection between your history and your health is real. So is the possibility of meaningful change.
The MAP Tool maps your situation to root cause. It does not guess. It follows the thread until it finds something real.
Start Your Map